QDB
LIVE

Serial Number

87771736

Owner

Quanticision Diagnostics, Inc

First Use Date

Sep 4, 2018

Filing Date

Jan 26, 2018

Add to watchlist:

No watchlists yet
View on USPTO

QDB Trademark

Serial Number: 87771736 • Registration: 6322540

QDB is a trademark filed by Quanticision Diagnostics, Inc on January 26, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Quanticision Diagnostics, Inc

421 Granville Rd.
Chapel Hill, NC 27514

Entity Type: 03

Trademark Details

Filing Date

January 26, 2018

Registration Date

April 13, 2021

First Use Anywhere

September 4, 2018

First Use in Commerce

September 4, 2018

Published for Opposition

July 3, 2018

Goods & Services

Diagnostic agents, preparations and substances for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents and media for medical and veterinary diagnostic purposes

Consulting services in the fields of diagnostic medical testing and nutrition; health care services, namely, providing a database in the field of cancer information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Computer diagnostic services; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; providing a website featuring information about investigational medical devices, diagnostics and drugs; providing medical testing services and information in the field of cancer research and disease classification

Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; diagnostic preparations for clinical or medical laboratory use; diagnostic preparations for scientific or research use; diagnostic preparations for scientific use; diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for scientific or research use; diagnostic reagents for scientific use; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use

Filing History

TEAS SECTION 8 & 15 RECEIVED
Jun 5, 2026 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 13, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 13, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 9, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 6, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 4, 2021 SUPC
USE AMENDMENT FILED
Feb 22, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 22, 2021 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 19, 2020 EXRA
SOU EXTENSION 4 GRANTED
Sep 18, 2020 EX4G
SOU EXTENSION 4 FILED
Aug 20, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 20, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 6, 2020 EXRA
SOU EXTENSION 3 GRANTED
Mar 5, 2020 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 5, 2020 AITU
SOU EXTENSION 3 FILED
Feb 24, 2020 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 24, 2020 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 24, 2020 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 24, 2020 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 27, 2019 EXRA
SOU EXTENSION 2 GRANTED
Aug 24, 2019 EX2G
SOU EXTENSION 2 FILED
Aug 24, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 24, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 28, 2019 EXRA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 26, 2019 TCCA
SOU EXTENSION 1 GRANTED
Feb 26, 2019 EX1G
SOU EXTENSION 1 FILED
Feb 26, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 26, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 28, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 3, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 3, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 13, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 17, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
May 16, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 16, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
May 16, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 16, 2018 CNEA
ASSIGNED TO EXAMINER
May 9, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 8, 2018 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 7, 2018 NWOS
NEW APPLICATION ENTERED
Jan 30, 2018 NWAP